AVE 20.0% 0.3¢ avecho biotechnology limited

prophase financials, page-33

  1. 379 Posts.
    Tangent Thanks. We clearly see the position very similarly. Your posts somewhat reassuring in giving reasoned chapter & verse that Management have at least proceeded to this point within normal disciplines.

    I recall when I was working for a major multinational consumer products company - 30 years ago! - it was received wisdom that their last succesful new brand/product launch, as opposed to revamps of established brands, had been before World War 2. That hurdle was, in fact, overcome at that time & a new one succesfully punted - but the expertise & resources behind it were enormous & it took time.

    The other, recent side of the bet, which may have influenced POH(?), was the Roddicks & 'Bodyshop'. A concept for its times, outside the box. Elixia will go into a crowded market of products with similar claims from established stables.

    How to get noticed & more importantly stocked & pushed by significant outlets? I shall be fascinated to read here of how their strategy develops, as much perhaps as by the results. I value this board for that input.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $408 154.2K

Buyers (Bids)

No. Vol. Price($)
61 90794613 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 54998583 13
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.